This Research Brief summarizes the relationship between (1) co-payments and compliance for patients whose doctors prescribed cholesterol-lowering drugs, and (2) compliance and subsequent use of expensive health care services.
Cutting drug copayments on cholesterol-lowering medication for the sickest patients would avert nearly 80,000 hospitalizations and more than 31,000 emergency room visits each year — accounting for the more than $1 billion in savings.
The U.S. military health care system has experienced rapid growth in expenditures over the past decade. To lower costs, it should discourage retirees' use of retail pharmacies and carefully implement a three-tier drug benefit.
Examines the effects of Medigap prescription drug benefits on elderly prescription drug spending and Medicare spending in order to estimate the potential offset savings that the Medicare prescription drug program may generate.
Implementing a modest catastrophic benefit with low-income subsidies would provide valuable insurance to the Medicare population. It also would provide a fiscally prudent alternative, allowing policymakers to better gauge future program costs and beneficiary behavior.
Education Ph.D. in health economics, Johns Hopkins Bloomberg School of Public Health; B.S. in political science, Santa Clara University; B.A. in Italian studies, Santa Clara University